These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Oral high-dose methylprednisolone and intravenous immunoglobulin treatments in adult chronic idiopathic thrombocytopenic purpura. Altintop L; Albayrak D Am J Hematol; 1997 Nov; 56(3):191-2. PubMed ID: 9371535 [TBL] [Abstract][Full Text] [Related]
44. Treatment of Children with Persistent and Chronic Idiopathic Thrombocytopenic Purpura: 4 Infusions of Rituximab and Three 4-Day Cycles of Dexamethasone. Oved JH; Lee CSY; Bussel JB J Pediatr; 2017 Dec; 191():225-231. PubMed ID: 29173312 [TBL] [Abstract][Full Text] [Related]
45. Duration and morbidity of chronic immune thrombocytopenic purpura in children: five-year follow-up of a Nordic cohort. Rosthøj S; Rajantie J; Treutiger I; Zeller B; Tedgård U; Henter JI; Acta Paediatr; 2012 Jul; 101(7):761-6. PubMed ID: 22429281 [TBL] [Abstract][Full Text] [Related]
46. [Long-term follow-up of chronic idiopathic thrombocytopenic purpura in children]. Amendola G; Danise P; D'Arco A Pediatr Med Chir; 2000; 22(1):39-41. PubMed ID: 11387765 [TBL] [Abstract][Full Text] [Related]
47. 5- to 16-year follow-up following splenectomy in chronic immune thrombocytopenic purpura in children. El-Alfy MS; El-Tawil MM; Shahein N Acta Haematol; 2003; 110(1):20-4. PubMed ID: 12975552 [TBL] [Abstract][Full Text] [Related]
48. Platelet kinetic study in patients with idiopathic thrombocytopenic purpura (ITP) refractory or relapsing after corticosteroid treatment. Rossi G; Cattaneo C; Motta M; Pizzocaro C; Lanzi S; Pouchè A Hematol J; 2002; 3(3):148-52. PubMed ID: 12111651 [TBL] [Abstract][Full Text] [Related]
49. Rituximab (anti-CD20 monoclonal antibody) in children with chronic refractory symptomatic immune thrombocytopenic purpura: efficacy and safety of treatment. Parodi E; Nobili B; Perrotta S; Rosaria Matarese SM; Russo G; Licciardello M; Zecca M; Locatelli F; Cesaro S; Bisogno G; Giordano P; De Mattia D; Ramenghia U Int J Hematol; 2006 Jul; 84(1):48-53. PubMed ID: 16867902 [TBL] [Abstract][Full Text] [Related]
50. The clinical outcome of 260 pediatric ITP patients in one center. Akbayram S; Dogan M; Ustyol L; Akgun C; Peker E; Bilici S; Caksen H; Oner AF Clin Appl Thromb Hemost; 2011; 17(6):E30-5. PubMed ID: 20713486 [TBL] [Abstract][Full Text] [Related]
51. Long-term outcome following splenectomy for chronic and persistent immune thrombocytopenia (ITP) in adults and children : Splenectomy in ITP. Ahmed R; Devasia AJ; Viswabandya A; Lakshmi KM; Abraham A; Karl S; Mathai J; Jacob PM; Abraham D; Srivastava A; Mathews V; George B Ann Hematol; 2016 Sep; 95(9):1429-34. PubMed ID: 27370992 [TBL] [Abstract][Full Text] [Related]
52. Low rate of long-lasting remissions after successful treatment of immune thrombocytopenic purpura with rituximab. Schweizer C; Reu FJ; Ho AD; Hensel M Ann Hematol; 2007 Oct; 86(10):711-7. PubMed ID: 17622529 [TBL] [Abstract][Full Text] [Related]
53. Head trauma and intracranial hemorrhage in children with idiopathic thrombocytopenic purpura. Alterkait A; Jamjoom R; Ratnapalan S Pediatr Emerg Care; 2015 Jun; 31(6):454-8. PubMed ID: 26035504 [TBL] [Abstract][Full Text] [Related]
54. The clinical course of immune thrombocytopenic purpura in children who did not receive intravenous immunoglobulins or sustained prednisone treatment. Dickerhoff R; von Ruecker A J Pediatr; 2000 Nov; 137(5):629-32. PubMed ID: 11060527 [TBL] [Abstract][Full Text] [Related]
55. A multicenter study of the treatment of childhood chronic idiopathic thrombocytopenic purpura with anti-D. Andrew M; Blanchette VS; Adams M; Ali K; Barnard D; Chan KW; DeVeber LB; Esseltine D; Israels S; Korbrinsky N J Pediatr; 1992 Apr; 120(4 Pt 1):522-7. PubMed ID: 1313096 [TBL] [Abstract][Full Text] [Related]
56. Predictive value of response to steroid therapy on response to splenectomy in children with immune thrombocytopenic purpura. Hollander LL; Leys CM; Weil BR; Rescorla FJ Surgery; 2011 Oct; 150(4):643-8. PubMed ID: 22000175 [TBL] [Abstract][Full Text] [Related]
57. Treatment of childhood acute immune thrombocytopenic purpura with high-dose methylprednisolone, intravenous immunoglobulin, or the combination of both. Gereige RS; Barrios NJ P R Health Sci J; 2000 Mar; 19(1):15-8. PubMed ID: 10761200 [TBL] [Abstract][Full Text] [Related]
58. Plasma soluble interleukin-2 receptor levels in patients with idiopathic thrombocytopenic purpura. Erduran E; Aslan Y; Aliyazicioglu Y; Mocan H; Gedik Y Am J Hematol; 1998 Feb; 57(2):119-23. PubMed ID: 9462543 [TBL] [Abstract][Full Text] [Related]
59. An analysis of outcomes and treatment costs for children undergoing splenectomy for chronic immune thrombocytopenia purpura. Gwilliam NR; Lazar DA; Brandt ML; Mahoney DH; Wesson DE; Mazziotti MV; Nuchtern JG; Lee TC J Pediatr Surg; 2012 Aug; 47(8):1537-41. PubMed ID: 22901913 [TBL] [Abstract][Full Text] [Related]
60. Randomized trial of anti-D immunoglobulin versus low-dose intravenous immunoglobulin in the treatment of childhood chronic idiopathic thrombocytopenic purpura. El Alfy MS; Mokhtar GM; El-Laboudy MA; Khalifa AS Acta Haematol; 2006; 115(1-2):46-52. PubMed ID: 16424649 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]